middle.news
Australian Clinical Labs Grows EBIT and Margins Despite Market Challenges
8:08am on Monday 17th of August, 2026 AEST
•
Healthcare
Read Story
Australian Clinical Labs Grows EBIT and Margins Despite Market Challenges
8:08am on Monday 17th of August, 2026 AEST
Key Points
Underlying EBIT up 1.7% with margin expansion to 9.4%
Revenue declined 0.7% due to Medicare fee cuts and market softness
Underlying NPAT rose 4.3% supported by cost discipline and buybacks
Final dividend increased to 9.25 cents per share, fully franked
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Australian Clinical Labs (ASX:ACL)
OPEN ARTICLE